The DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5
Open accessAbstract
The gut microbiota plays a crucial role in regulating many physiological systems of the host, including the metabolic and immune system. Disturbances in microbiota composition are increasingly correlated with disease; however, the underlying mechanisms are not well understood. Recent evidence suggests that changes in microbiota composition directly affect the metabolism of bile salts. Next to their role in digestion of dietary fats, bile salts function as signaling molecules for bile salt receptors such as Farnesoid X receptor (FXR) and G protein-coupled bile acid receptor (TGR5). Complementary to their role in metabolism, FXR and TGR5 are shown to play a role in intestinal homeostasis and immune regulation. This review presents an overview of evidence showing that changes in bile salt pool and composition due to changes in gut microbial composition contribute to the pathogenesis of inflammatory bowel disease and metabolic disease, possibly through altered activation of TGR5 and FXR. We further discuss how dietary interventions, such as pro- and synbiotics, may be used to treat metabolic disease and inflammatory bowel disease (IBD) through normalization of bile acid dysregulation directly or indirectly through normalization of the intestinal microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In the case of probiotics with typical BSH activity, the process is likely related to the deconjugation of conjugated BAs.32,33”
From Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans (2024) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Self-citationFunctional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Flagged first, then by citations
1 of the 148 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–136 of 136
Role of metabolites derived from gut microbiota in inflammatory bowel disease
Zheng, L., Wen, X., & Duan, S.-L. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i9.2658 · Cited by 1
Connection between Dysbiosis and Diet
Nag, S., Srivastava, N., Dutta, R., Bagchi, A., Adur, I., & Chakraborty, S. (2023) · Wiley eBooks · doi:10.1002/9781119904786.ch6 · Cited by 1
Surgical management of diabetes mellitus: future outlook (part 3)
Sazhin, A. V., Khusyainova, A. I., & Petukhov, V. A. (2017) · Endoscopic Surgery · doi:10.17116/endoskop201723354-64
Microbiome abnormalities and retinal disease
Barr, L. C., Hazari, H., & Rullo, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98338-9.00010-4
Microbiome-Immune Dynamics: Insights into Infectious Diseases
Rafinezhad, N. (2024) · SVOA Microbiology · doi:10.58624/svoamb.2024.05.048
Antiobesity effects of secondary metabolites: Molecular mechanisms and therapeutic potential
Rehman, K., & Akash, M. S. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-44135-6.00016-4
Wang, J., Cheng, M., Huang, F., Chen, L., Xu, W., Cai, J., Chen, Z., Zhao, Y., & Zhang, X. (2026) · Animals · doi:10.3390/ani16040575
Shen, W., Zhu, W., Xie, L., & Luo, C. (2026) · European journal of medical research · doi:10.1186/s40001-026-04212-3
Huynh, Q.-P., Quan, Q.-D., Ho, V.-T., Le, Q.-T., Nguyen, H.-C., & Tran, H.-D. (2026) · Biology · doi:10.3390/biology15070557
Muhasina, K. M., Ghosh, P., Deepika, N. P., Nagappan, K., Palaniswamy, D. S., Uddin, M. E., & Hassan, M. A. (2026) · Springer eBooks · doi:10.1007/978-981-95-7494-0_10
Probiotic, synbiotic effects on the gut–liver axis: omics-enabled mechanisms and therapeutic windows
Oriquat, G., El‐Sehrawy, A. A. M. A., Abdulsahib, W. K., Mustafa, W. W., Jyothi, S. R., Nayak, P. P., Janney, J. B., Singh, G., Sinha, A., & Yazdi, F. (2026) · Future Microbiology · doi:10.1080/17460913.2026.2684877
Cao, J., Jin, Y.-W., Li, Q.-Z., & Zhang, L. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100806
Ghaffari, M., Stoschus, A., Diesing, L. E., Schuchardt, S., & Hammon, H. M. (2026) · Journal of Dairy Science · doi:10.3168/jds.2026-28947
El‐Sehrawy, A. A. M. A., Oriquat, G., Rizaev, J., Yuldasheva, S. Z., Shakhmurova, G., Abdul, N. H., Singh, R., & Bainsal, N. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.107079
Microbiota and lipid mediators: from molecular crosstalk to therapeutic opportunities
Gökcen, B. B., Atabılen, B., Güneş, B. D., Dazıroğlu, M. E. Ç., Özer, Ş. D., Biten, A. A., Pagano, E., Nanì, M. F., Romano, B., Ağagündüz, D., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1836931
Wang, Z., Gao, Q., Li, S. B., Fang, Z., Hu, L., Li, R., Zeng, Z., Liu, Y., Li, C., & Chen, H. Y. (2026) · Food & Function · doi:10.1039/d6fo02528e
Silent allies: non-living microbes shaping the future of cardiometabolic health
Saraf‐Bank, S., Mehrabani, S., & Khodarahmi, M. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107452
Decoding the Gut Microbiome and Its Interactions in Animals: Mechanisms of Action
Roy, A. A., & Nandhini, M. (2026) · Springer eBooks · doi:10.1007/978-981-92-0002-3_8
From Microbiomes to Precision Livestock Nutrition: An AI-Enabled Policy Roadmap for Africa
Ncube, K. T., & Tugizimana, F. (2026) · Agriculture · doi:10.3390/agriculture16161718
Cai, W., Yang, D., Li, H., Zhang, C., Che, H., & Li, H. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109728
AlRamadneh, T. N., Rizaev, J., Hanumanthayya, M., Al-Hussein, M. A., Mutee, A. F., Buriev, M., Jumaniyazova, N., & Shefali (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1918510 · Cited by 1
Gut microbiome-immune-metabolic axis in fatigue: mechanistic insights and food science approaches
Kim, J., Son, B., Yoo, W., & Shin, H. (2026) · Food Science and Biotechnology · doi:10.1007/s10068-026-02282-x
The Bile Acid–Diet–Microbiome Axis in Clostridioides difficile Infection
Trofin, F., Buzilă, E. R., Iancu, I. R., Tuchiluş, C., Temneanu, O. R., Iancu, L. S., Vlad, M. A., Anton-Păduraru, D.-T., Armașu, I., Bădescu, A. C., et al. (2026) · Nutrients · doi:10.3390/nu18172872
Metabolic Signatures Associated with COVID-19 Vaccination in Serum from Healthy Individuals
AlEissa, M. M., Nimer, R. M., AlMalki, R. H., AlAhmari, R., Alsaieedi, A., Al-Rukhayes, M., Saleh, N. M., Albugami, R. R., AlQurashi, R. A., Hawsa, E. A., et al. (2026) · Vaccines · doi:10.3390/vaccines14090771
Lubaba, M. I., Mohammad, N., Paromi, I. N., Tusher, M. M. H., Asrafuzzaman, M., & Rokeya, B. (2026) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2026.100112
He, X., Zhang, T., Li, Y., 邱云顺, Wang, C., Wang, H., Liu, L., Wang, Y., Zhang, G., & Feng, Z. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1958426
Hasanuzzaman, M., Bang, C. S., Lee, J. J., & Gong, E. J. (2026) · Journal of Korean Medical Science · doi:10.3346/jkms.2026.41.e335
Joshi, S., Bhati, D., Dobhal, A., Kaur, R., Moger, R., & Kumar, S. (2026) · Exploration of Foods and Foodomics · doi:10.37349/eff.2026.1010193
Microbiome‐Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease
Maghembe, R. S., Damian, D., Bahati, S. Y., & Makaranga, A. (2026) · FASEB BioAdvances · doi:10.1096/fba.2026-00201
Malhotra, A., Rao, G. M., Marathe, A., Rai, S., Rani, V. S., Patil, A., Upadhya, D., & Chakrapani, M. (2026) · Oxidative Medicine and Cellular Longevity · doi:10.1155/omcl/5350976
The role of plant sterols in modulating the gut microbiota: implications for health and disease
Musto, L., Alegría, A., García‐Llatas, G., & Ruiz‐Rico, M. (2026) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2026.106169
Metadata
- Authors
- Baars, A., Oosting, A., Knol, J., Garssen, J., & Van Bergenhenegouwen, J.
- Affiliations
- Nutricia Research (Netherlands) (NL)
- Utrecht University (NL)
- Nutricia Research, 3584 CT, Utrecht, The Netherlands
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2015-10-10
- Volume
- 3
- Issue
- 4
- Pages
- 641-666
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC5023267
- OpenAlex
- W1894632157
- Cited by
- 135
- References
- 148
- Citations by year
- 2026: 43 · 2025: 22 · 2024: 12 · 2023: 15 · 2022: 12 · 2021: 11 · 2020: 6 · 2019: 5 · 2018: 7 · 2017: 1 · 2016: 1
- FWCI
- 0.29
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut microbiota, inflammatory bowel disease, metabolic disorders, bile acid receptors, farnesoid X receptor, TGR5, bile salt metabolism, intestinal homeostasis, immune regulation, dietary intervention, microbiota-targeted therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
